Eagle Pharmaceuticals shares owned by Acadian Asset Management
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Acadian Asset Management
from 13F filings
Historical chart of Acadian Asset Management investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Eagle Pharmaceuticals by Acadian Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $26k | 7.2k | 3.63 |
2024-06-30 | $147k | 26k | 5.57 |
2024-03-31 | $274k | 52k | 5.22 |
2023-09-30 | $3.7M | 237k | 15.76 |
2023-06-30 | $4.4M | 225k | 19.42 |
2023-03-31 | $6.1M | 215k | 28.35 |
2022-12-31 | $6.8M | 232k | 29.21 |
2022-09-30 | $8.2M | 311k | 26.42 |
2022-06-30 | $8.3M | 187k | 44.43 |
2022-03-31 | $6.9M | 140k | 49.45 |
2021-12-31 | $5.4M | 106k | 50.89 |
2021-09-30 | $7.2M | 129k | 55.73 |
2021-06-30 | $11M | 262k | 42.80 |
2021-03-31 | $8.9M | 213k | 41.74 |
2020-12-31 | $8.0M | 172k | 46.58 |
2020-09-30 | $7.2M | 169k | 42.48 |
2020-06-30 | $5.7M | 118k | 47.98 |
2020-03-31 | $4.0M | 88k | 46.00 |
2019-12-31 | $1.4M | 24k | 60.08 |
2019-09-30 | $1.7M | 31k | 56.57 |
2019-06-30 | $1.9M | 35k | 55.66 |
2019-03-31 | $210k | 4.1k | 50.63 |
2018-12-31 | $121k | 3.0k | 40.23 |
2018-09-30 | $115k | 1.7k | 69.61 |
2017-12-31 | $201k | 3.8k | 53.44 |
2017-09-30 | $456k | 7.6k | 59.71 |